advances in lithium-ion batteries 2002 - schalkwijk & scrosati

advances in lithium-ion batteries 2002 - schalkwijk & scrosati

advances in lithium-ion batteries 2002 - schalkwijk & scrosati

... electrodes treated in the same solutions). ADVANCES IN LITHIUM-ION BATTERIES 19 20 Surface Films in Lithium-Ion Batteries ADVANCES IN LITHIUM-ION BATTERIES 21 22 Surface Films in Lithium-Ion Batteries Figure ... Spotnitz explains the non-trivial nature of scale-up of Li- Ion cells; and van Schalkwijk explains the intricacies of charging, monitoring and control....

Ngày tải lên: 16/04/2014, 11:22

513 451 0
Recent Advances in Plant Biotechnology

Recent Advances in Plant Biotechnology

... oleanane-type triterpene saponins and share β-amyrin as a common biosynthetic intermediate. Specific oxidations of β-amyrin at C-11 and C-30 positions leading to glycyrrhizin are blocked in the ... addition, he took part in several visiting research inves- tigator positions in Germany. First, he was a visiting scientist under collaborative grant project DLR in Heinrich-Heine-University...

Ngày tải lên: 02/10/2012, 10:48

404 475 0
Báo cáo y học: "Advances in immunomodulating therapy of HBV infection"

Báo cáo y học: "Advances in immunomodulating therapy of HBV infection"

... chronic HBV infection. Interleukin-12 (IL-12) IL-12 is a heterodimeric cytokine produced by antigen-presenting cells that have the ability to induce interferon-γ (IFN-γ) secretion by T and ... seen in 30.0%. Loss of HBeAg occurred in 26.3% and 21.1% had HBeAg to anti-HBe seroconversion. No patients had a lost of HBsAg or anti-HBs seroconversion. Thymosin -1 Thymosin -1 is a 28-a...

Ngày tải lên: 02/11/2012, 11:17

6 406 0
Báo cáo y học: "Advances in Molecular Diagnosis of HBV Infection and Drug Resistance"

Báo cáo y học: "Advances in Molecular Diagnosis of HBV Infection and Drug Resistance"

... high intermediate low no LiPA 5% low low-intermediate yes intermediate low low yes Florescence nd intermediate intermediate no intermediate intermediate intermediate yes MALDI-TOF <5% intermediate ... transmission). For instance, this implies differing testing-treatment schemes depending on whether high-incidence, less affluent regions or low-incidence, high-affluent areas are being ta...

Ngày tải lên: 03/11/2012, 09:41

9 591 0
Advances in StentTherapy for Ischaemic Heart Disease

Advances in StentTherapy for Ischaemic Heart Disease

... acid Mizoribine Cyclosporine Tranilast Biorest QP-2, Taxol Actinomycin Methothrexate Angiopeptin Vincristine Mitomycine Statins C-myc antisense Sirolimus (& analogs) RestenASE 2-chloro- deoxyadenosine PCNA Ribozyme Batimastat Prolyl ... (n=852) Proximal In- stent Distal P<0.001 P<0.001 P<0.001 P<0.001 P<0.001 P<0.001 Mak Heart Pharmacologic Approaches Anti-inflammatory...

Ngày tải lên: 26/01/2013, 11:02

38 376 0
w